Raleigh company wins approval for pain patch
A small Raleigh drug company won regulatory approval for its first product today, a pain patch for cancer patients.
Pain Therapeutics, Inc., a biopharmaceutical company, has received a $5 million milestone payment from King Pharmaceuticals, Inc., its exclusive commercial partner for abuse-resistant prescription pain medications.